The effect of lidocaine sprayed on the major duodenal papilla on the frequency of post-ERCP pancreatitis
Acute pancreatitis remains a serious cause of ERCP-related morbidity. Topical application of lidocaine reportedly blunts cholecystokinin release from intestinal mucosa and reduces sphincter of Oddi spasm. A randomized trial was conducted to evaluate the effect of lidocaine sprayed on the major duode...
Gespeichert in:
| Veröffentlicht in: | Gastrointestinal endoscopy 2004-02, Vol.59 (2), p.179-184 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 184 |
|---|---|
| container_issue | 2 |
| container_start_page | 179 |
| container_title | Gastrointestinal endoscopy |
| container_volume | 59 |
| creator | Schwartz, Jeremy J Lew, Ronald J Ahmad, Nuzhat A Shah, Janak N Ginsberg, Gregory G Kochman, Michael L Brensinger, Colleen M Long, William B |
| description | Acute pancreatitis remains a serious cause of ERCP-related morbidity. Topical application of lidocaine reportedly blunts cholecystokinin release from intestinal mucosa and reduces sphincter of Oddi spasm. A randomized trial was conducted to evaluate the effect of lidocaine sprayed on the major duodenal papilla on the frequency of post-ERCP pancreatitis. Secondary outcomes evaluated were ease of cannulation and severity of post-ERCP pancreatitis.
Patients undergoing ERCP were randomized in blocks of 6 to have 10 mL of either 1% lidocaine or normal saline solution sprayed on the major papilla before cannulation. Patients were observed for the development of post-ERCP pancreatitis. Patient history- and procedure-related variables were recorded.
A total of 326 patients were enrolled, of whom 32 were excluded after randomization but before analysis. Of patients analyzed, 145 were randomized to treatment with lidocaine and 149 to placebo. No patient was lost to follow-up. There was no significant difference noted in patient history- or procedure-related variables. Seven patients in the lidocaine group and 5 in the placebo group developed post-ERCP pancreatitis (
p
=
0.73). Ease of cannulation did not differ between the two groups.
Lidocaine sprayed on the major papilla does not decrease the frequency of post-ERCP pancreatitis. |
| doi_str_mv | 10.1016/S0016-5107(03)02540-9 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80121621</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0016510703025409</els_id><sourcerecordid>80121621</sourcerecordid><originalsourceid>FETCH-LOGICAL-c457t-689ecd39e3ff31303cb5f6f4e4c90de736e0eb0842272c163dd23668621d814c3</originalsourceid><addsrcrecordid>eNqFkU1PGzEQhi1UVELan9BqL0VwWDr-WO_uqaoivqRIVAXOlmOPhaPNemtvkPLvcUhojlw8Bz8z8-oZQr5RuKRA5c8HyG9ZUajPgV8AqwSU7RGZUGjrUtZ1-4lM_iMn5DSlJQA0jNPP5ISKWlS8aSfk-fEZC3QOzVgEV3TeBqN9j0Uaot6gLUJfjBlZ6WWIhV0Hi73uikEPvuv0-6-L-G-NvdlsZwwhjeXV39mfTPUmoh796NMXcux0l_Drvk7J0_XV4-y2nN_f3M1-z0sjqnosZdOisbxF7hynHLhZVE46gcK0YLHmEgEX0AjGamao5NYyLmUjGbUNFYZPydlu7hBDzpRGtfLJYA7bY1gn1QBlNNMZrHagiSGliE4N0a903CgKaqtYvSlWW38KuHpTrNrc932_YL1YoT107Z1m4Mce0MnozsVswacDV1WUNVJk7teOw6zjxWNUyfgsEa2P-RzKBv9BlFdLp5fi</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80121621</pqid></control><display><type>article</type><title>The effect of lidocaine sprayed on the major duodenal papilla on the frequency of post-ERCP pancreatitis</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Schwartz, Jeremy J ; Lew, Ronald J ; Ahmad, Nuzhat A ; Shah, Janak N ; Ginsberg, Gregory G ; Kochman, Michael L ; Brensinger, Colleen M ; Long, William B</creator><creatorcontrib>Schwartz, Jeremy J ; Lew, Ronald J ; Ahmad, Nuzhat A ; Shah, Janak N ; Ginsberg, Gregory G ; Kochman, Michael L ; Brensinger, Colleen M ; Long, William B</creatorcontrib><description>Acute pancreatitis remains a serious cause of ERCP-related morbidity. Topical application of lidocaine reportedly blunts cholecystokinin release from intestinal mucosa and reduces sphincter of Oddi spasm. A randomized trial was conducted to evaluate the effect of lidocaine sprayed on the major duodenal papilla on the frequency of post-ERCP pancreatitis. Secondary outcomes evaluated were ease of cannulation and severity of post-ERCP pancreatitis.
Patients undergoing ERCP were randomized in blocks of 6 to have 10 mL of either 1% lidocaine or normal saline solution sprayed on the major papilla before cannulation. Patients were observed for the development of post-ERCP pancreatitis. Patient history- and procedure-related variables were recorded.
A total of 326 patients were enrolled, of whom 32 were excluded after randomization but before analysis. Of patients analyzed, 145 were randomized to treatment with lidocaine and 149 to placebo. No patient was lost to follow-up. There was no significant difference noted in patient history- or procedure-related variables. Seven patients in the lidocaine group and 5 in the placebo group developed post-ERCP pancreatitis (
p
=
0.73). Ease of cannulation did not differ between the two groups.
Lidocaine sprayed on the major papilla does not decrease the frequency of post-ERCP pancreatitis.</description><identifier>ISSN: 0016-5107</identifier><identifier>EISSN: 1097-6779</identifier><identifier>DOI: 10.1016/S0016-5107(03)02540-9</identifier><identifier>PMID: 14745389</identifier><identifier>CODEN: GAENBQ</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Administration, Topical ; Ampulla of Vater - drug effects ; Ampulla of Vater - metabolism ; Biological and medical sciences ; Cholangiopancreatography, Endoscopic Retrograde - adverse effects ; Cholecystokinin - metabolism ; Female ; Follow-Up Studies ; Gastroenterology. Liver. Pancreas. Abdomen ; Humans ; Lidocaine - administration & dosage ; Liver. Biliary tract. Portal circulation. Exocrine pancreas ; Male ; Medical sciences ; Middle Aged ; Other diseases. Semiology ; Pancreatitis - etiology ; Pancreatitis - prevention & control ; Prospective Studies ; Treatment Outcome</subject><ispartof>Gastrointestinal endoscopy, 2004-02, Vol.59 (2), p.179-184</ispartof><rights>2004 American Society for Gastrointestinal Endoscopy</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c457t-689ecd39e3ff31303cb5f6f4e4c90de736e0eb0842272c163dd23668621d814c3</citedby><cites>FETCH-LOGICAL-c457t-689ecd39e3ff31303cb5f6f4e4c90de736e0eb0842272c163dd23668621d814c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0016-5107(03)02540-9$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15512864$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14745389$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schwartz, Jeremy J</creatorcontrib><creatorcontrib>Lew, Ronald J</creatorcontrib><creatorcontrib>Ahmad, Nuzhat A</creatorcontrib><creatorcontrib>Shah, Janak N</creatorcontrib><creatorcontrib>Ginsberg, Gregory G</creatorcontrib><creatorcontrib>Kochman, Michael L</creatorcontrib><creatorcontrib>Brensinger, Colleen M</creatorcontrib><creatorcontrib>Long, William B</creatorcontrib><title>The effect of lidocaine sprayed on the major duodenal papilla on the frequency of post-ERCP pancreatitis</title><title>Gastrointestinal endoscopy</title><addtitle>Gastrointest Endosc</addtitle><description>Acute pancreatitis remains a serious cause of ERCP-related morbidity. Topical application of lidocaine reportedly blunts cholecystokinin release from intestinal mucosa and reduces sphincter of Oddi spasm. A randomized trial was conducted to evaluate the effect of lidocaine sprayed on the major duodenal papilla on the frequency of post-ERCP pancreatitis. Secondary outcomes evaluated were ease of cannulation and severity of post-ERCP pancreatitis.
Patients undergoing ERCP were randomized in blocks of 6 to have 10 mL of either 1% lidocaine or normal saline solution sprayed on the major papilla before cannulation. Patients were observed for the development of post-ERCP pancreatitis. Patient history- and procedure-related variables were recorded.
A total of 326 patients were enrolled, of whom 32 were excluded after randomization but before analysis. Of patients analyzed, 145 were randomized to treatment with lidocaine and 149 to placebo. No patient was lost to follow-up. There was no significant difference noted in patient history- or procedure-related variables. Seven patients in the lidocaine group and 5 in the placebo group developed post-ERCP pancreatitis (
p
=
0.73). Ease of cannulation did not differ between the two groups.
Lidocaine sprayed on the major papilla does not decrease the frequency of post-ERCP pancreatitis.</description><subject>Administration, Topical</subject><subject>Ampulla of Vater - drug effects</subject><subject>Ampulla of Vater - metabolism</subject><subject>Biological and medical sciences</subject><subject>Cholangiopancreatography, Endoscopic Retrograde - adverse effects</subject><subject>Cholecystokinin - metabolism</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Humans</subject><subject>Lidocaine - administration & dosage</subject><subject>Liver. Biliary tract. Portal circulation. Exocrine pancreas</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Other diseases. Semiology</subject><subject>Pancreatitis - etiology</subject><subject>Pancreatitis - prevention & control</subject><subject>Prospective Studies</subject><subject>Treatment Outcome</subject><issn>0016-5107</issn><issn>1097-6779</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1PGzEQhi1UVELan9BqL0VwWDr-WO_uqaoivqRIVAXOlmOPhaPNemtvkPLvcUhojlw8Bz8z8-oZQr5RuKRA5c8HyG9ZUajPgV8AqwSU7RGZUGjrUtZ1-4lM_iMn5DSlJQA0jNPP5ISKWlS8aSfk-fEZC3QOzVgEV3TeBqN9j0Uaot6gLUJfjBlZ6WWIhV0Hi73uikEPvuv0-6-L-G-NvdlsZwwhjeXV39mfTPUmoh796NMXcux0l_Drvk7J0_XV4-y2nN_f3M1-z0sjqnosZdOisbxF7hynHLhZVE46gcK0YLHmEgEX0AjGamao5NYyLmUjGbUNFYZPydlu7hBDzpRGtfLJYA7bY1gn1QBlNNMZrHagiSGliE4N0a903CgKaqtYvSlWW38KuHpTrNrc932_YL1YoT107Z1m4Mce0MnozsVswacDV1WUNVJk7teOw6zjxWNUyfgsEa2P-RzKBv9BlFdLp5fi</recordid><startdate>20040201</startdate><enddate>20040201</enddate><creator>Schwartz, Jeremy J</creator><creator>Lew, Ronald J</creator><creator>Ahmad, Nuzhat A</creator><creator>Shah, Janak N</creator><creator>Ginsberg, Gregory G</creator><creator>Kochman, Michael L</creator><creator>Brensinger, Colleen M</creator><creator>Long, William B</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20040201</creationdate><title>The effect of lidocaine sprayed on the major duodenal papilla on the frequency of post-ERCP pancreatitis</title><author>Schwartz, Jeremy J ; Lew, Ronald J ; Ahmad, Nuzhat A ; Shah, Janak N ; Ginsberg, Gregory G ; Kochman, Michael L ; Brensinger, Colleen M ; Long, William B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c457t-689ecd39e3ff31303cb5f6f4e4c90de736e0eb0842272c163dd23668621d814c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Administration, Topical</topic><topic>Ampulla of Vater - drug effects</topic><topic>Ampulla of Vater - metabolism</topic><topic>Biological and medical sciences</topic><topic>Cholangiopancreatography, Endoscopic Retrograde - adverse effects</topic><topic>Cholecystokinin - metabolism</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Humans</topic><topic>Lidocaine - administration & dosage</topic><topic>Liver. Biliary tract. Portal circulation. Exocrine pancreas</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Other diseases. Semiology</topic><topic>Pancreatitis - etiology</topic><topic>Pancreatitis - prevention & control</topic><topic>Prospective Studies</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schwartz, Jeremy J</creatorcontrib><creatorcontrib>Lew, Ronald J</creatorcontrib><creatorcontrib>Ahmad, Nuzhat A</creatorcontrib><creatorcontrib>Shah, Janak N</creatorcontrib><creatorcontrib>Ginsberg, Gregory G</creatorcontrib><creatorcontrib>Kochman, Michael L</creatorcontrib><creatorcontrib>Brensinger, Colleen M</creatorcontrib><creatorcontrib>Long, William B</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Gastrointestinal endoscopy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schwartz, Jeremy J</au><au>Lew, Ronald J</au><au>Ahmad, Nuzhat A</au><au>Shah, Janak N</au><au>Ginsberg, Gregory G</au><au>Kochman, Michael L</au><au>Brensinger, Colleen M</au><au>Long, William B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The effect of lidocaine sprayed on the major duodenal papilla on the frequency of post-ERCP pancreatitis</atitle><jtitle>Gastrointestinal endoscopy</jtitle><addtitle>Gastrointest Endosc</addtitle><date>2004-02-01</date><risdate>2004</risdate><volume>59</volume><issue>2</issue><spage>179</spage><epage>184</epage><pages>179-184</pages><issn>0016-5107</issn><eissn>1097-6779</eissn><coden>GAENBQ</coden><abstract>Acute pancreatitis remains a serious cause of ERCP-related morbidity. Topical application of lidocaine reportedly blunts cholecystokinin release from intestinal mucosa and reduces sphincter of Oddi spasm. A randomized trial was conducted to evaluate the effect of lidocaine sprayed on the major duodenal papilla on the frequency of post-ERCP pancreatitis. Secondary outcomes evaluated were ease of cannulation and severity of post-ERCP pancreatitis.
Patients undergoing ERCP were randomized in blocks of 6 to have 10 mL of either 1% lidocaine or normal saline solution sprayed on the major papilla before cannulation. Patients were observed for the development of post-ERCP pancreatitis. Patient history- and procedure-related variables were recorded.
A total of 326 patients were enrolled, of whom 32 were excluded after randomization but before analysis. Of patients analyzed, 145 were randomized to treatment with lidocaine and 149 to placebo. No patient was lost to follow-up. There was no significant difference noted in patient history- or procedure-related variables. Seven patients in the lidocaine group and 5 in the placebo group developed post-ERCP pancreatitis (
p
=
0.73). Ease of cannulation did not differ between the two groups.
Lidocaine sprayed on the major papilla does not decrease the frequency of post-ERCP pancreatitis.</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>14745389</pmid><doi>10.1016/S0016-5107(03)02540-9</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0016-5107 |
| ispartof | Gastrointestinal endoscopy, 2004-02, Vol.59 (2), p.179-184 |
| issn | 0016-5107 1097-6779 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_80121621 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Administration, Topical Ampulla of Vater - drug effects Ampulla of Vater - metabolism Biological and medical sciences Cholangiopancreatography, Endoscopic Retrograde - adverse effects Cholecystokinin - metabolism Female Follow-Up Studies Gastroenterology. Liver. Pancreas. Abdomen Humans Lidocaine - administration & dosage Liver. Biliary tract. Portal circulation. Exocrine pancreas Male Medical sciences Middle Aged Other diseases. Semiology Pancreatitis - etiology Pancreatitis - prevention & control Prospective Studies Treatment Outcome |
| title | The effect of lidocaine sprayed on the major duodenal papilla on the frequency of post-ERCP pancreatitis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T15%3A59%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20effect%20of%20lidocaine%20sprayed%20on%20the%20major%20duodenal%20papilla%20on%20the%20frequency%20of%20post-ERCP%20pancreatitis&rft.jtitle=Gastrointestinal%20endoscopy&rft.au=Schwartz,%20Jeremy%20J&rft.date=2004-02-01&rft.volume=59&rft.issue=2&rft.spage=179&rft.epage=184&rft.pages=179-184&rft.issn=0016-5107&rft.eissn=1097-6779&rft.coden=GAENBQ&rft_id=info:doi/10.1016/S0016-5107(03)02540-9&rft_dat=%3Cproquest_cross%3E80121621%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80121621&rft_id=info:pmid/14745389&rft_els_id=S0016510703025409&rfr_iscdi=true |